Table 3.
Case | Clinical diagnosis | Pathological diagnosis | Amyloid score (Thal) | Braak | CERAD | Gender | Age | PMI (hrs) |
---|---|---|---|---|---|---|---|---|
MSA-8 | Spinocerebellar ataxia | MSA | 1 | II | sparse | Female | 76 | 12 |
MSA-9 | MSA-C | MSA | 0 | 0 | none | Male | 68 | 8 |
MSA-10 | MSA-C | MSA | 0 | II | none | Male | 72 | 9 |
LBD-6 | PD | LBD diffuse neocortical | 2 | III/IV | frequent | Female | 82 | 5 |
LBD-7 | DLB | LBD diffuse neocortical | 1 | I/II | none | Male | 68 | 15 |
LBD-8 | Corticobasal syndrome | LBD diffuse neocortical | 3 | I/II | moderate | Male | 83 | 20 |
Listed are the clinical and pathological diagnoses, the sex, age at death, amyloid score (Thal), Braak stage and CERAD ratings. DLB dementia with Lewy body, LBD Lewy body dementia, MSA-C multiple system atrophy with predominant cerebellar ataxia, MSA-P multiple system atrophy with predominant Parkinsonism, PD Parkinson’s disease, PMI postmortem interval